Date Initiated by Firm | October 11, 2016 |
Date Posted | November 09, 2016 |
Recall Status1 |
Terminated 3 on May 17, 2017 |
Recall Number | Z-0379-2017 |
Recall Event ID |
75448 |
Product Classification |
Acid, lactic, enzymatic method - Product Code KHP
|
Product | ARCHITECT Lactic Acid Part # 09D891T21
The Lactic Acid assay is used for the quantitation of lactic acid in human plasma. |
Code Information |
Lot: 31497UN14 Exp.: 17 Oct. 2016; Lot: 09353UNI15 Exp.: 12 Feb. 2017; Lot: 45216UN15 12 May 2017; Lot: 14596UN15 Exp.: 30 Jul. 2017; Lot: 37055UN15 Exp.: 12 Oct. 2017; Lot: 14782UN16 Exp.: 21 Apr. 2018 |
Recalling Firm/ Manufacturer |
Abbott Laboratories 100 Abbott Park Rd Abbott Park IL 60064-3502
|
For Additional Information Contact | Albert A. Chianello 847-937-2550 |
Manufacturer Reason for Recall | Abbott has identified negative interference from the drug N-Acetyl Cysteine (NAC) with the ARCHITECT Lactic Acid reagent (LN 9D89-21). |
FDA Determined Cause 2 | Under Investigation by firm |
Action | Abbott Laboratories sent an Product Correction Immediate Action Required letter dated October 10, 2016, to all affected customers.
Please review this letter with your Medical Director
Taking the above information into consideration, you may continue to use ARCHITECT Lactic Acid reagent (LN 9D89-21)
Please complete and return the Customer Reply Form
If you have forwarded the product listed above to other laboratories, please inform them of this Product Correction and provide to them a copy of this letter
Please retain this letter for your laboratory records.
If you or any of the health care providers you serve have any questions regarding this information, U.S. Customers please contact Customer Service at 1-877-4ABBOTT (available 24 hours a day, 7 days a week). Customers outside the U.S., please contact your local area Customer Service.
For further questions please call (847) 937-2550. |
Quantity in Commerce | 26, 837 kits |
Distribution | Nationwide and Worldwide Distribution. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|